Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
United Therapeutics Corporation (NASDAQ: UTHR)
UTHR Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
19.40%
Analyst Rating:
BUY
Analyst Forecast (1yr):
3.10%
UTHR Stock Analysis
UTHR
PE Ratio:
20.3
UTHR
PEG Ratio:
1.4
UTHR
Forward EPS Growth (12 month):
14.40%
UTHR
PS Ratio:
7.4
UTHR
PSG Ratio:
0.5
UTHR
Forward Revenue Growth (12 month):
14.40%
UTHR Articles
No data was found